We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1808:TSEAvic Shougang Biomass Analysis

Data as of 2026-06-24 - not real-time

NT$31.25

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Run Long Construction posted an eye‑catching 173% revenue growth and solid profitability margins (gross 33.6%, operating 22.8%, net 20.2%), but its balance sheet is strained with a debt‑to‑equity ratio of 215% and a payout ratio of 163% that fuels a 7.41% dividend yield well above earnings. The stock trades at a trailing P/E of 22.98—comfortably below the industry average of 32.78—while the forward P/E collapses to 14.67, suggesting earnings are expected to improve. However, a discounted cash‑flow model pins a fair value near TWD 16.7, less than half the current price of TWD 31.25, indicating the market may be pricing in overly optimistic growth or ignoring the leverage burden.
Technically, the share sits just above its 20‑day SMA (30.79) and 50‑day SMA (29.89) but remains under the 200‑day SMA (32.75), with a bearish MACD crossover and a neutral RSI of 53.5. Volume is rising, yet the 30‑day volatility spikes at 37% and the beta is virtually zero, implying the price moves largely on company‑specific factors. Coupled with a maximum drawdown of –36% and an “Extreme Greed” market sentiment, the stock appears overvalued and carries elevated risk.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram and proximity to resistance
  • Current price far above DCF fair value
  • High leverage amplifying downside risk

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Forward P/E suggests earnings improvement
  • Strong revenue growth and profit margins
  • Debt load remains a concern but cash flow is positive

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • Unsustainable dividend payout exceeding earnings
  • Elevated debt‑to‑equity ratio limiting financial flexibility
  • Valuation gap between market price and intrinsic DCF estimate

Key Metrics & Analysis

Financial Health

Revenue Growth17344.90%
Profit Margin20.19%
P/E Ratio23.0
ROE18.35%
ROA3.77%
Debt/Equity215.31
P/B Ratio2.0
Op. Cash FlowNT$5.0B
Free Cash FlowNT$1.1B
Industry P/E32.8

Technical Analysis

TrendNeutral
RSI53.5
SupportNT$28.05
ResistanceNT$33.15
MA 20NT$30.79
MA 50NT$29.89
MA 200NT$32.75
MACDBearish
VolumeIncreasing
Fear & Greed Index85.89

Valuation

Fair ValueNT$16.70
GradeOvervalued
TypeBlend
Dividend Yield7.41%

Risk Assessment

Beta0.06
Volatility37.03%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.